HomeCompareATVI vs MRK

ATVI vs MRK: Dividend Comparison 2026

ATVI yields 1.05% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATVI wins by $14.7K in total portfolio value· pulled ahead in Year 9
10 years
ATVI
ATVI
● Live price
1.05%
Share price
$94.42
Annual div
$0.99
5Y div CAGR
56.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71.5K
Annual income
$22,936.56
Full ATVI calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ATVI vs MRK

📍 ATVI pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATVIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATVI + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATVI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATVI
Annual income on $10K today (after 15% tax)
$89.12/yr
After 10yr DRIP, annual income (after tax)
$19,496.08/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ATVI beats the other by $11,167.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATVI + MRK for your $10,000?

ATVI: 50%MRK: 50%
100% MRK50/50100% ATVI
Portfolio after 10yr
$64.1K
Annual income
$16,367.35/yr
Blended yield
25.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ATVI right now

ATVI
Analyst Ratings
36
Buy
24
Hold
Consensus: Buy
Price Target
$93.88
-0.6% upside vs current
Range: $77.00 — $116.00
Altman Z
7.6
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATVI buys
8
MRK buys
0
PoliticianChamberTickerTypeAmountDate
Richard W. Allen🏢 House$ATVI▼ Sell$1,001 - $15,0002023-10-13
Richard W. Allen🏢 House$ATVI▼ Sell$15,001 - $50,0002023-10-13
Ro Khanna🏢 House$ATVI▲ Buy$1,001 - $15,0002023-10-10
Seth Moulton🏢 House$ATVI▼ Sell$500,001 - $1,000,0002023-08-18
Seth Moulton🏢 House$ATVI▼ Sell$50,001 - $100,0002023-08-18
Ro Khanna🏢 House$ATVI▲ Buy$1,001 - $15,0002023-06-26
Seth Moulton🏢 House$ATVI▼ Sell$100,001 - $250,0002023-06-13
Ro Khanna🏢 House$ATVI▼ Sell$15,001 - $50,0002023-05-23
Tommy Tuberville🏛 Senate$ATVI▼ Sell$100,001 - $250,0002023-04-26
Tommy Tuberville🏛 Senate$ATVI▼ Sell$100,001 - $250,0002023-04-26
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATVIMRK
Forward yield1.05%2.76%
Annual dividend / share$0.99$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR56.6%32.7%
Portfolio after 10y$71.5K$56.8K
Annual income after 10y$22,936.56$9,798.13
Total dividends collected$47.5K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$93.88$128.54

Year-by-year: ATVI vs MRK ($10,000, DRIP)

YearATVI PortfolioATVI Income/yrMRK PortfolioMRK Income/yrGap
1$10,864$164.20$11,206$366.19$342.00MRK
2$11,886$261.08$12,650$502.35$764.00MRK
3$13,136$418.03$14,407$694.19$1.3KMRK
4$14,731$676.15$16,585$967.82$1.9KMRK
5$16,872$1,109.79$19,342$1,363.89$2.5KMRK
6$19,914$1,860.29$22,913$1,947.19$3.0KMRK
7$24,521$3,213.40$27,662$2,823.89$3.1KMRK
8$32,029$5,791.09$34,159$4,173.35$2.1KMRK
9← crossover$45,341$11,070.49$43,337$6,308.80+$2.0KATVI
10$71,452$22,936.56$56,776$9,798.13+$14.7KATVI

ATVI vs MRK: Complete Analysis 2026

ATVIStock

Activision Blizzard, Inc., together with its subsidiaries, develops and publishes interactive entertainment content and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Activision, Blizzard, and King. It develops and distributes content and services on video game consoles, personal computers, and mobile devices, including subscription, full-game, and in-game sales, as well as by licensing software to third-party or related-party companies that distribute Activision and Blizzard products. The company also maintains a proprietary online gaming service, Battle.net that facilitates digital distribution of content, online social connectivity, and the creation of user-generated content. In addition, it operates esports leagues and offer digital advertising content; and provides warehousing, logistics, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company's key product franchises include Call of Duty, World of Warcraft, Diablo, Hearthstone, Overwatch, Overwatch League, and Candy Crush. It serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, and game specialty stores through third-party distribution and licensing arrangements. The company is headquartered in Santa Monica, California.

Full ATVI Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ATVI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATVI vs SCHDATVI vs JEPIATVI vs OATVI vs KOATVI vs MAINATVI vs JNJATVI vs ABBVATVI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.